Down Syndrome
Conditions
Keywords
Mini-Trampoline, Spirometry, Down Syndrome
Brief summary
The purpose of this study is to examine the effects of rebound therapy on ventilatory functions in children with Down Syndrome.
Detailed description
Down syndrome (DS) is one of the common congenital anomalies associated with a high rate of various medical disorders including congenital cardiac defects, visual and auditory affection, musculoskeletal system, and autoimmune disorders. Respiratory involvement is common in DS and is a leading cause of death. Rebound therapy from quality of mini trampoline provides all benefits of other aerobic exercise without the stress impact usually associated with vigrous activity. Several studies support the use of rebound therapy among different areas while, there is no research conducted on ventilatory functions in children with Down Syndrome. Hence, there is need to study the effect of rebount therapy on ventilatory functions in children with Down Syndrome. Fourty children with Down syndrome (based on power analysis) from both sexes (9-13 years) will be recruited from different schools of special education. They will be divided randomly into control group (20 children) and study group (20 children). The control group will receive a chest physical therapy protocol that included respiratory exercises and incentive spirometer training. The study group will receive a rebound therapy using mini trampoline.
Interventions
OTHERChest Physical Therapy Protocol
The chest physical therapy protocol include respiratory exercises and incentive spirometer training.
OTHERRebound Therapy Protocol
The chest physical therapy protocol include respiratory exercises and incentive spirometer training + rebound therapy protocol using mini-trampoline training
Sponsors
Beni-Suef University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
9 Years to 13 Years
Healthy volunteers
No
Inclusion criteria
* Children ages will be ranged from 9 to 13 years old. * Mild and moderate mental retardation with IQ level between 50-70 based on Stanford-Binet intelligence scale. * Functional hearing and vision. * Independent standing and walking.
Exclusion criteria
* Symptomatic pain. * Musculoskeletal problems or/ atlanto-axial instability. * Rheumatic and congenital heart disease * History of previous surgical operation * Regular participation in any sport activities.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Forced Vital Capacity (FVC) | Up to 12 weeks | Spirometry will be used to measure forced vital capacity (FVC). It is the maximum volume of gas that can be expired when the child exhales as forcefully and as rapidly as possible after a maximal inspiration to assess the overall ability to move air in and out of the lungs. It is expressed in liter/minute. |
| Forced Expiratory Volume in the First Second (FEV1) | Up to 12 weeks | Spirometry will be used to measure forced expiratory volume in the first second (FEV1). It is the volume of gas expired over a given time interval (the first second) from the beginning of the FVC maneuver that reflects airflow in the large airways. It is expressed in liter/minute. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Chest Expansion | Up to 12 weeks | Tape measures will be used to measure chest expansion. |
| Functional Mobility | Up to 12 weeks | Six-minute walk test will be used for measuring functional mobility. It is a sub-maximal test of aerobic capacity, in which the subjects walk as far as possible in 6 minutes (min.) around a premeasured distance |
Contacts
CONTACTEman Wagdy, PH.D
Outcome results
None listed